Starling Oncology (STLN) Asset Utilization Ratio (2021 - 2026)
Analysis
Starling Oncology (STLN) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | 1.25 |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | 0.70 |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | 0.84 |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 0.80 |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 1.15 |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | 0.97 |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 1.67 |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 0.98 |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 0.78 |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | 3.39 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 |
| Mar 31, 2026 | 3.28 |
| Dec 31, 2025 | 3.06 |
| Sep 30, 2025 | 2.85 |
| Jun 30, 2025 | 2.62 |
| Mar 31, 2025 | 2.39 |
| Dec 31, 2024 | 2.24 |
| Sep 30, 2024 | 2.11 |
| Jun 30, 2024 | 1.88 |
| Mar 31, 2024 | 1.66 |
| Dec 31, 2023 | 1.52 |
| Sep 30, 2023 | 1.38 |
| Jun 30, 2023 | 1.26 |
| Mar 31, 2023 | 1.10 |
| Dec 31, 2022 | 0.93 |
| Sep 30, 2022 | 0.99 |
| Jun 30, 2022 | 1.11 |
| Mar 31, 2022 | 1.02 |
| Dec 31, 2021 | 0.94 |